Pathogenic and non-pathogenic polyglutamine tracts have similar structural properties: towards a length-dependent

Fabrice A C Klein1, Annalisa Pastore, Laura Masino

  • 1Department of Molecular Pathology, Institut de Génétique et Biologie Moléculaire et Cellulaire, UMR 7104-CNRS/INSERM/ULP, BP10142, 67404 Illkirch Cédex, CU de Strasbourg, France.

Summary

Polyglutamine (polyQ) tracts in neurodegenerative diseases are toxic due to their inherent nature, not a specific structural change. Toxicity increases gradually with polyQ tract length, challenging the threshold hypothesis.